Ocugen, Inc. (OCGN)
1.02
+0.02
(+2.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.02
0.00 (0.00%)
After-Hours: 20:00
Ocugen Profit Margin (Quarterly) : -1.67K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.67K% |
| March 31, 2026 | -1.25K% |
| December 31, 2025 | |
| September 30, 2025 | -1.14K% |
| June 30, 2025 | -1.07K% |
| March 31, 2025 | -1.04K% |
| December 31, 2024 | -1.82K% |
| September 30, 2024 | -1.14K% |
| June 30, 2024 | -1.34K% |
| March 31, 2024 | -1.18K% |
| December 31, 2023 | -778.6% |
| September 30, 2023 | -316.8% |
| June 30, 2023 | -4.76K% |
| March 31, 2023 | -3.91K% |
| December 31, 2022 | -2.55K% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -8.48K% |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Gilead Sciences, Inc. | -134.2% |
| MannKind Corp. | -17.40% |
| Nektar Therapeutics | -401.0% |
| Vertex Pharmaceuticals, Inc. | 32.89% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -121.5% |
| Return on Invested Capital | -200.6% |
| Gross Profit Margin (Quarterly) | 60.62% |
| Operating Margin (Quarterly) | -1.11K% |
| Return on Net Operating Assets | -568.4% |